Cargando…
The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics
BACKGROUND: Chronic kidney disease (CKD) is an important cause of morbidity and mortality worldwide. There is a lack of information on epidemiology and progression of CKD in low–middle income countries. The Indian Chronic Kidney Disease (ICKD) study aims to identify factors that associate with CKD p...
Autores principales: | Kumar, Vivek, Yadav, Ashok Kumar, Sethi, Jasmine, Ghosh, Arpita, Sahay, Manisha, Prasad, Narayan, Varughese, Santosh, Parameswaran, Sreejith, Gopalakrishnan, Natarajan, Kaur, Prabhjot, Modi, Gopesh K, Kamboj, Kajal, Kundu, Monica, Sood, Vivek, Inamdar, Neeraj, Jaryal, Ajay, Vikrant, Sanjay, Nayak, Saurabh, Singh, Shivendra, Gang, Sishir, Baid-Agrawal, Seema, Jha, Vivekanand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757418/ https://www.ncbi.nlm.nih.gov/pubmed/35035937 http://dx.doi.org/10.1093/ckj/sfab149 |
Ejemplares similares
-
Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease—findings from the ICKD study
por: Prasad, Narayan, et al.
Publicado: (2022) -
Prescription Practices in Patients With Mild to Moderate CKD in India
por: Prasad, Narayan, et al.
Publicado: (2021) -
Cholecalciferol supplementation and angiogenic markers in chronic kidney disease
por: Kaur, Jaskiran, et al.
Publicado: (2022) -
Serum myo-inositol oxygenase levels at hospital discharge predict progression to chronic kidney disease in community-acquired acute kidney injury
por: Kakkanattu, Tom Jose, et al.
Publicado: (2022) -
A randomized trial of once daily versus twice daily dosing of oral iron in CKD
por: Sood, Vivek, et al.
Publicado: (2023)